First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
Clinical trial NCT07700160 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07700160
- Sponsor
- VelaVigo Bio Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-13
- Primary completion
- 2029-07-07
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.